We have developed and implemented mass spectrometry-based methods for proteomics and metabolomics, including targeted and untargeted analyses of hormones, lipids and small signaling molecules in human cerebrospinal fluid and blood samples. These signals are further connected to biological pathways and demographic patient data. We are currently involved in three large efforts;
Characterization and stratification of multiple sclerosis phenotypes
We are also part of the EU Horizon 2020 project PhenoMeNal with focus on implementing clinical metabolomics into the clinic.
Kim Kultima, Associate Professor
Torbjörn Åkerfeldt, Physician
Payam Khoonsari Emami, Postdoctorial researcher
Niclas Rollborn, Laboratory engineer
Best Technical Solution – OpenHack 2017
June 7, 2017Stephanie participated in OpenHack Uppsala 2017 together with her brother and two friends. They created an application that matches your abilities with mined skill keywords in job ads from Arbetsförme...
The Uppsala team presented at the Vårmöte klinisk kemi
April 6, 2017The Uppsala team presented at the Vårmöte klinisk kemi, 5-7 April in Tylösand, Sweden. Here Torbjörn is presenting our MS based assays for analysing PEth (a marker for alcohol consumption measured in ...
presenting on PhenoMeNal workshop in Halle, Germany
April 4, 2017The Uppsala team presented at the PhenoMeNal Workflow Workshop, 4-5 April in IPB Halle, Germany. The presentations covered the two workflows which have been developed by the Uppsala team in PhenoMeNal...